Story · Medicine & Biotech

Beyond the Lipid Panel: Elevated Lp(a), Lifetime Risk and What the Evidence Says About Aspirin- Dr Ambar Bhatnagar

1 outlet · first reported by Medical Dialogues 19h ago

Coverage, in order

  1. 19h ago
    Medical Dialogues India obscure
    Beyond the Lipid Panel: Elevated Lp(a), Lifetime Risk and What the Evidence Says About Aspirin- Dr Ambar Bhatnagar

    A reassuring lipid panel can still hide an inherited cardiovascular risk. Lipoprotein(a) [Lp(a)] escapes routine lipid testing (8), and a 2024 NHANES III analysis asked whether it could identify who may benefit from aspirin in primary prevention (1). Who is the primary-prevention patient? A midlife…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.